Structure of the small G protein Rap2 in a non-catalytic complex with GTP

Proteins: Structure, Function and Genetics

Volumn 37, Issue 3, 1999, Pages 465-473

  Menetrey J ^a   Cherfils, J ^a  

^a LABORATOIRE D ENZYMOLOGIE ET BIOCHIMIE STRUCTURALES   (France)

Author keywords

Disorder; Flexibility; G protein; GTPase; Hinge residue; Ras; Structure

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE TRIPHOSPHATASE; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; HYDROGEN;

ARTICLE; CONTROLLED STUDY; ENERGY; ENTROPY; ENZYME ACTIVITY; HYDROGEN BOND; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN NUCLEIC ACID INTERACTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE;

CRYSTALLOGRAPHY, X-RAY; GTP-BINDING PROTEINS; GUANOSINE TRIPHOSPHATE; MODELS, MOLECULAR; PROTEIN CONFORMATION; RAP GTP-BINDING PROTEINS;

EID: 0344604228     PISSN: 08873585     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0134(19991115)37:3<465::AID-PROT13>3.0.CO;2-O     Document Type: Article

References (55)

1. de Vos AM, Tong L, Milburn MV, et al. Three-dimensional structure of an oncogene protein: catalytic domain of human c-H-ras p21. Science 1988;239:888-893.
2. Pai EF, Kabsch W, Krengel U, Holmes KC, John J, Wittinghofer A. Structure of the guanine-nucleotide-binding domain of the Ha-ras oncogene product p21 in the triphosphate conformation. Nature 1989;341:209-214.
3. Geyer M, Wittinghofer A. GEFs, GAPs, GDIs and effectors: taking a closer (3D) look at the regulation of Ras-related GTP-binding proteins. Curr Opin Struct Biol 1997;7:786-792.
4. Bos JL. All in the family? New insights and questions regarding interconnectivity of Ras, Rap1 and Ral. Embo J 1998;17:6776-6782.
5. Marshall CJ. Ras effectors. Curr Opin Cell Biol 1996;8:197-204.
6. Pizon V, Chardin P, Lerosey I, Olofsson B, Tavitian A. Human cDNAs rap1 and rap2 homologous to the Drosophila gene Dras3 encode proteins closely related to ras in the "effector" region. Oncogene 1988;3:201-204.
7. Kitayama H, Sugimoto Y, Matsuzaki T, Ikawa Y, Noda M. A ras-related gene with transformation suppressor activity. Cell 1989;56:77-84.
8. Jimenez B, Pizon V, Lerosey I, Beranger F, Tavitian A, de Gunzburg J. Effects of the ras-related rap2 protein on cellular proliferation. Int J Cancer 1991;49:471-479.
9. Frech M, John J, Pizon V, et al. Inhibition of GTPase activating protein stimulation of Ras-p21 GTPase by the Krev-1 gene product. Science 1990;249:169-171.
10. van den Berghe N, Cool RH, Horn G, Wittinghofer A. Biochemical characterization of C3G: an exchange factor that discriminates between Rap1 and Rap2 and is not inhibited by Rap1A(S17N). Oncogene 1997;15:845-850.
11. Janoueix-Lerosey I, Pasheva E, de Tand MF, Tavitian A, de Gunzburg J. Identification of a specific effector of the small GTP-binding protein Rap2. Eur J Biochem 1998;252:290-298.
12. de Rooij J, Zwartkruis FJ, Verheijen MH, et al. Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature 1998;396:474-477.
13. Kawasaki H, Springett GM, Mochizuki N, et al. A family of cAMP-binding proteins that directly activate Rap1. Science 1998; 282:2275-2279.
14. Cherfils J, Ménétrey J, Le Bras G, Janoueix-Lerosey I, de Gunzburg J, Garel JR, Auzat I. Crystal structures of the small G protein Rap2A in complex with its substrate GTP, with GDP and with GTPgammaS. Embo J 1997;16:5582-5591.
15. Otwinowski Z. Oscillation data reduction program. In: Sawyer L, Isaacs N, Bailey S, editors. CCP4 study weekend: data collection and processing. Warrington, UK: Daresbury Laboratory; 1993. p 56-62.
16. Navaza J. AMoRe: an automated package for molecular replacement. Acta Crystallogr A 1994;50:157-163.
17. Brünger AT, Karplus M, Petsko GA. Crystallographic refinement by simulated annealing: application to crambin. Acta Crystallogr A 1989;45:50-61.
18. Roussel A, Inisan AG, Cambillaud C. TURBO. AFMB and Bio-Graphics, Marseille, France.
19. The CCP4 suite: program for protein crystallography. Acta Crystallogr D 1994;50:760-763.
20. Lerosey I, Chardin P, de Gunzburg J, Tavitian A. The product of the rap2 gene, member of the ras superfamily. Biochemical characterization and site-directed mutagenesis. J Biol Chem 1991;266:4315-4321.
21. Hilgenfeld R. How do the GTPases really work? Nat Struct Biol 1995;2:3-6.
22. Maegley KA, Admiraal SJ, Herschlag D. Ras-catalyzed hydrolysis of GTP: a new perspective from model studies. Proc Natl Acad Sci USA 1996;93:8160-8166.
23. Hirshberg M, Stockley RW, Dodson G, Webb MR. The crystal structure of human rac1, a member of the rho-family complexed with a GTP analogue. Nat Struct Biol 1997;4:147-152.
24. Nassar N, Horn G, Herrmann C, Scherer A, McCormick F, Wittinghofer A. The 2.2 Å crystal structure of the Ras-binding domain of the serine/threonine kinase c-Raf1 in complex with Rap1A and a GTP analogue. Nature 1995;375:554-560.
25. Scheffzek K, Ahmadian MR, Kabsch W, et al. The Ras-RasGAP complex: structural basis for GTPase activation and its loss in oncogenic Ras mutants. Science 1997;277:333-338.
26. Rittinger K, Walker PA, Eccleston JF, Smerdon SJ, Gamblin SJ. Structure at 1.65 Å of RhoA and its GTPase-activating protein in complex with a transition-state analogue. Nature 1997;389:758-762.
27. Nassar N, Hoffman GR, Manor D, Clardy JC, Cerione RA. Structures of Cdc42 bound to the active and catalytically compromised forms of Cdc42GAP. Nat Struct Biol 1998;5:1047-1052.
28. Ihara K, Muraguchi S, Kato M, et al. Crystal structure of human RhoA in a dominantly active form complexed with a GTP analogue. J Biol Chem 1998;273:9656-9666.
29. Vetter IR, Nowak C, Nishimoto T, Kuhlmann J, Wittinghofer A. Structure of a Ran-binding domain complexed with Ran bound to a GTP analogue: implications for nuclear transport. Nature 1999;398:39-46.
30. Nassar N, Horn G, Herrmann C, Block C, Janknecht R, Wittinghofer A. Ras/Rap effector specificity determined by charge reversal. Nat Struct Biol 1996;3:723-729.
31. Scheidig AJ, Burmester C, Goody RS. Use of caged nucleotides to characterize unstable intermediates by X-ray crystallography. Methods Enzymol 1998;291:251-264.
32. Geyer M, Schweins T, Herrmann C, Prisner T, Wittinghofer A, Kalbitzer HR. Conformational transitions in p21ras and in its complexes with the effector protein Raf-RBD and the GTPase activating protein GAP. Biochemistry 1996;35:10308-10320.
33. Dumas JJ, Zhu Z, Connolly JL, Lambright DG. Structural basis of activation and GTP hydrolysis in rab proteins. Structure 1999;7: 413-423.
34. Ostermeier C, Brunger AT. Structural basis of Rab effector specificity: crystal structure of the small G protein Rab3A complexed with the effector domain of rabphilin-3A. Cell 1999;96:363-374.
35. Ninio J. Kinetic amplification of enzyme discrimination. Biochimie 1975;57:587-595.
36. Foschi M, Chari S, Dunn MJ, Sorokin A. Biphasic activation of p21ras by endothelin-1 sequentially activates the ERK cascade and phosphatidylinositol 3-kinase. Embo J 1997;16:6439-6451.
37. John J, Frech M., Wittinghofer, A. Biochemical properties of Ha-ras encoded p21 mutants and mechanism of the autophosphorylation reaction. J Biol Chem 1988;263:11792-11799.
38. Foster R, Hu KQ, Lu Y, Nolan KM, Thissen J, Settleman J. Identification of a novel human Rho protein with unusual properties: GTPase deficiency and in vivo farnesylation. Mol Cell Biol 1996;16:2689-2699.
39. Ungermann C, Sato K, Wickner W. Defining the functions of trans-SNARE pairs. Nature 1998;396:543-548.
40. Amor JC, Harrison DH, Kahn RA, Ringe D. Structure of the human ADP-ribosylation factor 1 complexed with GDP. Nature 1994;372:704-708.
41. Greasley SE, Jhoti H, Teahan C, et al. The structure of rat ADP-ribosylation factor-1 (ARF-1) complexed to GDP determined from two different crystal forms. Nat Struct Biol 1995;2:797-806.
42. Wei Y, Zhang Y, Derewenda U, et al. Crystal structure of RhoA-GDP and its functional implications. Nat Struct Biol 1997;4:699-703.
43. Goldberg J. Structural basis for activation of ARF GTPase: mechanisms of guanine nucleotide exchange and GTP-myristoyl switching. Cell 1998;95:237-248.
44. Berghuis AM, Lee E, Raw AS, Gilman AG, Sprang SR. Structure of the GDP-Pi complex of Gly203→Ala gialpha1: a mimic of the ternary product complex of galpha-catalyzed GTP hydrolysis. Structure 1996;4:1277-1290.
45. Fujita-Yoshigaki J, Shirouzu M, Ito Y, et al. A constitutive effector region on the C-terminal side of switch I of the Ras protein. J Biol Chem 1995;270:4661-4667.
46. Bae CD, Min DS, Fleming IN, Exton JH. Determination of interaction sites on the small G protein RhoA for phospholipase D. J Biol Chem 1998;273:11596-11604.
47. Aktories K. Rho proteins: targets for bacterial toxins. Trends Microbiol 1997;5:282-288.
48. Iiri T, Farfel Z, Bourne HR. G-protein diseases furnish a model for the turn-on switch. Nature 1998;394:35-38.
49. Boriack-Sjodin PA, Margarit SM, Bar-Sagi D, Kuriyan J. The structural basis of the activation of Ras by Sos. Nature 1998;394: 337-343.
50. Johnson LN, Lowe ED, Noble ME, Owen DJ. The structural basis for substrate recognition and control by protein kinases. FEBS Lett 1998;430:1-11.
51. Lo Conte L, Chothia C, Janin J. The atomic structure of protein-protein recognition sites. J Mol Biol 1999;285:2177-2198.
52. van den Berghe N, Cool HR, Wittinghofer A. Discriminatory residues in Ras and Rap for guanine Nucleotide Exchange Factor recognition. Biochemistry 1999;274:11078-11085.
53. Shirouzu M, Fujita-Yoshigaki J, Ito Y, Koide H, Nishimura S, Yokoyama S. A glutamic acid residue at position 31 of Ras protein is essential to the signal transduction for neurite outgrowth of PC12 cells and the stimulation of GTPase activity by GAPRas. Oncogene 1992;7:475-480.
54. Kavounis C, Verrotti AC, De Vendittis E, et al. Role of glycine-82 as a pivot point during the transition from the inactive to the active form of the yeast Ras2 protein. FEBS Lett 1991;281:235-239.
55. Wall MA, Coleman DE, Lee E, Iniguez-Lluhi JA. Posner BA, Gilman AG, Sprang SR. The structure of the G protein heterotrimer Gi alpha 1 beta 1 gamma 2. Cell 1995;83:1047-1058.